The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)
Abstract
Targeted therapies for cancer is a rapidly advancing field, but the identification of tumor-specific ligands has proven difficult. Chlorotoxin (CTX) is a small, 36 amino acid neurotoxin isolated from the venom of the Giant Yellow Israeli scorpion Leiurus Quinquestriatus. Interestingly, the peptide has been found to preferentially bind to a variety of human malignancies, but shows little or no binding to normal human tissues. A synthetic version of this peptide (TM-601) has been manufactured and covalently linked to iodine 131 (131I-TM-601) as a means of targeting radiation to tumor cells. Preclinical studies and Phase I clinical trials have been completed in patients with recurrent glioma, a type of malignant brain tumor. These studies demonstrated that intracavitary dosing of 131I-TM-601 appears safe, minimally toxic, and binds malignant glioma with high affinity and for long durations. A Phase II trial of this agent using higher doses of radioactivity and repeated local administrations is underway. In addition, enrolment has begun in a Phase I trial evaluating whether systemically delivered 131I-TM-601 can be used to image metastatic solid tumors and primary gliomas. Due to its small size, selective tumor binding properties, minimal toxicity and relative ease of manipulation, CTX represents a potentially important targeting agent for many cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Epidemiology and etiology of gliomas
Ohgaki, H., & Kleihues, P. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-0991-y · Cited by 1,252
Stummer, W., Novotny, A., Stepp, H., Goetz, C., Bise, K., & Reulen, H. J. (2000) · Journal of Neurosurgery · doi:10.3171/jns.2000.93.6.1003 · Cited by 881
Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms
Kelly, P. J., Daumas-Duport, C., Kispert, D. B., Kall, B. A., Scheithauer, B. W., & Illig, J. J. (1987) · Journal of Neurosurgery · doi:10.3171/jns.1987.66.6.0865 · Cited by 798
Rainov, N. G. (2000) · Human Gene Therapy · doi:10.1089/104303400750038499 · Cited by 698
Laws, E. R., Parney, I. F., Huang, W., Anderson, F., Morris, A. M., Asher, A., Lillehei, K. O., Bernstein, M., Brem, H., Sloan, A., et al. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.3.0467 · Cited by 670
Factors influencing survival in high-grade gliomas
Buckner, J. C. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.11.031 · Cited by 443
Diffusion-tensor imaging of white matter tracts in patients with cerebral neoplasm
Witwer, B. P., Moftakhar, R., Hasan, K. M., Deshmukh, P., Haughton, V., Field, A., Arfanakis, K., Noyes, J., Moritz, C. H., Meyerand, M. E., et al. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.3.0568 · Cited by 431
Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2
Deshane, J., Garner, C. C., & Sontheimer, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205662200 · Cited by 415
Lidar, Z., Mardor, Y., Jonas, T., Pfeffer, R., Faibel, M., Nass, D., Hadani, M., & Ram, Z. (2004) · Journal of Neurosurgery · doi:10.3171/jns.2004.100.3.0472 · Cited by 342
Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion
Lieberman, D. M., Laske, D. W., Morrison, P. F., Bankiewicz, K. S., & Oldfield, E. H. (1995) · Journal of Neurosurgery · doi:10.3171/jns.1995.82.6.1021 · Cited by 341
Modulation of Glioma Cell Migration and Invasion Using Cl−and K+Ion Channel Blockers
Soroceanu, L., Manning, T. J., & Sontheimer, H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05942.1999 · Cited by 306 · cited 2×
“MMP2 is considered a chloride channel-associated receptor, and is believed to indirectly regulate the chloride channels expressed by gliomas, but not normal human cells [50-52,55].”
BackgroundKlatzmann, D., Valery, C. A., Bensimon, G., Marro, B., Boyer, O., Mokhtari, K., Diquet, B., Salzmann, J.-L., Philippon, J., & Glioblastoma, S. G. O. G. T. F. (1998) · Human Gene Therapy · doi:10.1089/10430349850019436 · Cited by 269
Lyons, S. A., O'Neal, J., & Sontheimer, H. (2002) · Glia · doi:10.1002/glia.10083 · Cited by 263
Trask, T. W., Trask, R. P., Aguilar-Cordova, E., Shine, H. D., Wyde, P. R., Goodman, J. C., Hamilton, W. J., Rojas-Martinez, A., Chen, S.-H., Woo, S. L. C., et al. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0030 · Cited by 262
Reardon, D. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1389 · Cited by 255
Shand, N., Weber, F., Mariani, L., Bernstein, M., Gianella-Borradori, A., Long, Z., Sorensen, A. G., & Barbier, N. (1999) · Human Gene Therapy · doi:10.1089/10430349950016979 · Cited by 247
Current management of glioblastoma multiforme
Grossman, S. A., & Batara, J. F. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.07.005 · Cited by 241
Use of chlorotoxin for targeting of primary brain tumors.
Soroceanu, L., Gillespie, G. Y., Khazaeli, M. B., & Sontheimer, H. W. (1998) · PubMed · Cited by 237
Targeted therapy for brain tumours
Lesniak, M. S., & Brem, H. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1414 · Cited by 234
A role for ion channels in glioma cell invasion
MCFERRIN, M. B., & SONTHEIMER, H. (2006) · Neuron Glia Biology · doi:10.1017/s1740925x06000044 · Cited by 209
Biodegradable polymer implants to treat brain tumors
Brem, H., & Gabikian, P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00311-x · Cited by 192
Kunwar, S. (2003) · Local Therapies for Glioma Present Status and Future Developments · doi:10.1007/978-3-7091-6090-9_16 · Cited by 158
Johannesen, T. B., Langmark, F., & Lote, K. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.5.0854 · Cited by 131
Hadaczek, P., Kohutnicka, M., Krauze, M. T., Bringas, J., Pivirotto, P., Cunningham, J., & Bankiewicz, K. S. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.291 · Cited by 119
Expression of voltage-activated chloride currents in acute slices of human gliomas
Ullrich, N. J., Bordey, A., Gillespie, G. Y., & Sontheimer, H. W. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00456-9 · Cited by 107
Black, K. L., Cloughesy, T. F., Huang, S., Gobin, Y. P., Zhou, Y., Grous, J. J., Nelson, G., Farahani, K., Hoh, C. K., & Phelps, M. E. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.86.4.0603 · Cited by 93
Extent of Resection in Malignant Gliomas: a Critical Summary
Sawaya, R. A. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006167412835 · Cited by 92
Bucci, M. K., Maity, A. M., Janss, A. J., Belasco, J. B., Fisher, M. J., Tochner, Z. A., RORKE, L. B., Sutton, L. N., Phillips∥, P. C., & Shu, H. G. (2004) · Cancer · doi:10.1002/cncr.20422 · Cited by 92
Imaging glioma extent with 131I-TM-601.
Hockaday, D. C., Shen, S., Fiveash, J. B., Raubitschek, A. A., Colcher, D. M., Liu, A., Alvarez, V. L., & Mamelak, A. N. (2005) · PubMed · Cited by 90
Self-citationBiophysical and pharmacological characterization of chloride currents in human astrocytoma cells
Ullrich, N. J., & Sontheimer, H. W. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1511 · Cited by 86
Intraoperative infrared imaging of brain tumors
Gorbach, A. M., Heiss, J. D., Kopylev, L., & Oldfield, E. H. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.101.6.0960 · Cited by 84
Gururangan, S., Cokgor, I., Rich, J. N., Edwards, S., Affronti, M. L., Quinn, J. A., Herndon, J. E., Provenzale, J. M., McLendon, R. E., Tourt-Uhlig, S., et al. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.4.246 · Cited by 82
Human astrocytoma cells express a unique chloride current
Ullrich, N. J., Gillespie, G. Y., & Sontheimer, H. W. (1996) · Neuroreport · doi:10.1097/00001756-199604100-00013 · Cited by 58
Biology and treatment of malignant glioma.
Shapiro, W. R., & Shapiro, J. R. (1998) · PubMed · Cited by 56
Neuwelt, E. A., & Dahlborg, S. A. (1987) · Journal of Neuro-Oncology · doi:10.1007/bf00150611 · Cited by 49
EGFRvIII as a promising target for antibody-based brain tumor therapy
Kuan, C., Wikstrand, C. J., & Bigner, D. D. (2000) · Brain Tumor Pathology · doi:10.1007/bf02482738 · Cited by 49
Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice
Rustamzadeh, E., Hall, W. A., Todhunter, D. A., Vallera, V. D., Low, W. C., Liu, H., Panoskaltsis‐Mortari, A., & Vallera, D. A. (2006) · International Journal of Cancer · doi:10.1002/ijc.22278 · Cited by 44
Stereotactic Injection of DTI-015 into Recurrent Malignant Gliomas: Phase I/II Trial
Hassenbusch, S. J., Nardone, E. M., Levin, V. A., Leeds, N. E., & PIETRONIGRO, D. D. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80012-x · Cited by 43
Kirsten Hopkins, M. B., B.Sc. Christopher Chandler, M. B., B.Sc., J. E., F.R.C.Path. Tim Moss, M. B., & F.R.C.Path. Tim Moss, M. B. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00915-2 · Cited by 32
Convection-Enhanced and Local Delivery of Targeted Cytotoxins in the Treatment of Malignant Gliomas
Muro, K., Das, S., & Raizer, J. J. (2006) · Technology in Cancer Research & Treatment · doi:10.1177/153303460600500304 · Cited by 17
External beam and conformal radiotherapy in the management of gliomas
Short, S. C. (2003) · Springer eBooks · doi:10.1007/978-3-7091-6090-9_7 · Cited by 5
Cited by
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Role of Ion Channels and Transporters in Cell Migration
Schwab, A., Fabian, A., Hanley, P. J., & Stock, C. (2012) · Physiological Reviews · doi:10.1152/physrev.00018.2011 · Cited by 420
Niosomes: A review on niosomal research in the last decade
Bhardwaj, P., Tripathi, P., Gupta, R., & Pandey, S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101581 · Cited by 366
Scorpion venom components as potential candidates for drug development
Ortiz, E., Gurrola, G. B., Schwartz, E. F., & Possani, L. D. (2015) · Toxicon · doi:10.1016/j.toxicon.2014.11.233 · Cited by 335
In Vivo MRI Detection of Gliomas by Chlorotoxin‐Conjugated Superparamagnetic Nanoprobes
Sun, C., Veiseh, O., Gunn, J., Fang, C., Hansen, S., Lee, D., Sze, R., Ellenbogen, R. G., Olson, J., & Zhang, M. (2008) · Small · doi:10.1002/smll.200700784 · Cited by 329
Metadata
- Authors
- Mamelak, A. N., & Jacoby, D. B.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2007-03
- Volume
- 4
- Issue
- 2
- Pages
- 175-186
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2140222552
- Cited by
- 273
- References
- 43
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.